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In Singapore, after a major outbreak of dengue in 2005, 
another outbreak occurred in 2007. Laboratory-based sur-
veillance detected a switch from dengue virus serotype 1 
(DENV-1) to DENV-2. Phylogenetic analysis showed a 
clade replacement within DENV-2 cosmopolitan genotype, 
which accompanied the predominant serotype switch, and 
cocirculation of multiple genotypes of DENV-3.
D
engue poses a threat to public health in >100 countries 
worldwide. Despite improvements in diagnostics and 
clinical management, the number of dengue cases continues 
to rise globally; 2.5 billion persons are at risk for infection 
(1). Dengue virus (DENV) belongs to the genus Flavivirus 
and contains a positive-strand RNA genome that encodes 
3 structural proteins—core protein, membrane-associated 
protein, envelope protein—and 7 nonstructural proteins. 
DENV consists of 4 genetically and antigenically distinct 
serotypes, 1–4.
Singapore has seen a resurgence of dengue cases since 
the late 1980s, after 2 decades of successful control that re-
lied mostly on an integrated vector-control program (2,3). 
The recent epidemiology of dengue in Singapore is charac-
terized by a 5–6-year cycle; incidence rates increase within 
each cycle before collapsing into 1 or 2 lull years. Dur-
ing an unprecedented dengue outbreak in 2005, a total of 
14,006 cases and 27 deaths were reported (4). The outbreak 
was associated with a switch in predominant serotype, from 
DENV-2 to DENV-1, in 2004 (5,6). In 2007, Singapore ex-
perienced another dengue outbreak after a lull in 2006. We 
report the laboratory and surveillance ﬁ  ndings that assisted 
vector-control operations during the 2007 dengue outbreak 
in Singapore.
The Study
In Singapore in 2005, as part of an integrated vector-
control program, laboratory-based dengue virus surveil-
lance was established for close monitoring and investiga-
tion of the circulating dengue virus serotypes. Samples 
were sent to the Environmental Health Institute from Tan 
Tock Seng Hospital, which cares for ≈40% of all reported 
dengue patients in Singapore, and from a network of partici-
pating general practitioners throughout the country. PCR to 
detect dengue virus RNA and serotyping were performed 
at the Environmental Health Institute according to its in-
house real-time PCR protocol (7). The numbers of dengue-
positive samples serotyped were 186 in 2006, 889 in 2007, 
and 918 in 2008, and represent ≈10% of the total dengue 
cases reported each year by the Ministry of Health.
The envelope protein gene of DENV (≈1,480 nt) 
was ampliﬁ  ed by reverse transcription–PCR and directly 
sequenced by using an automated DNA sequencer (ABI 
3100; Applied Biosystems, Foster City, CA, USA). Se-
quences were aligned and submitted to GenBank (ac-
cession nos. GQ357666–892). Phylogenetic analysis of 
DENV sequences was conducted by using the maximum-
likelihood method as implemented in PAUP* software, 
version 4.0b10 (8), and compared with sequence data ob-
tained from GenBank.
During 2006–2008, all 4 DENV serotypes were de-
tected (Figure 1). DENV-1 (21.7%) and DENV-2 (69.3%) 
were the predominant serotypes throughout the study pe-
riod; DENV-3 (7.8%) and DENV-4 (1.2%) were less prev-
alent. In 2006, the number of DENV cases was relatively 
low, and DENV-1 remained the predominant serotype after 
the major 2004–2005 outbreak. During January–September 
2006, 75%–100% of samples collected each month con-
tained DENV-1. In early January 2007, the predominant 
circulating serotype switched from DENV-1 to DENV-2. 
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Figure 1. Trends of monthly dengue cases in Singapore, 2005–
2008, showing a switch in predominant serotype from dengue virus 
serotype 1 (DENV-1) to DENV-2 in January 2007 and cocirculation 
of all 4 serotypes with general dominance of DENV-1 and DENV-2 
and lesser circulation of DENV-3 and DENV-4. *From ≈10% of all 
dengue cases.Early detection of this switch warned of a possible upcom-
ing dengue outbreak. In response, an enhanced vector-con-
trol program was activated in February 2007. The propor-
tion of DENV-2–positive samples detected by PCR rose 
from 57.9% in January 2007 to a peak of 91.0% in July 
2007. This increase was accompanied by an increase in the 
total number of dengue cases reported by the Ministry of 
Health; cases peaked at 432 in the ﬁ  rst week of July 2007. 
By late August, the number of dengue cases fell to below 
the warning level (warning level = 256 cases/epidemiolog-
ic week) as reported by the Ministry of Health (9). During 
the switch in predominant serotype, fatality rates (0.32% 
in 2006 and 0.27% in 2007) and dengue hemorrhagic fe-
ver rates (2.4% in 2006 and 2.1% in 2007) did not differ 
substantially among the reported cases. During this same 
period of extensive surveillance, 5.2% of the samples in 
2007 and 10.8% in 2008 were detected as DENV-3. Our 
spatial analysis indicated localized emergence of DENV-3 
in the eastern region of the country in 2007 and in the cen-
tral region in 2008. Enhanced control was also attempted 
in these areas to prevent the spread of the serotype that had 
been uncommon in Singapore.
Phylogenetic analysis of DENV-2 envelope gene se-
quences showed that the switch in predominant serotype 
in early 2007 coincided with a clade replacement within 
DENV-2. During 2000–2008, 2 distinct subclades, with 
strong temporal topology, were found within the cosmo-
politan genotype (Figure 2). Speciﬁ  cally, DENV-2 iso-
lates obtained before 2007 formed the subclade herein 
referred to as the old clade, whereas isolates obtained in 
2007 and later formed the new clade with strong bootstrap 
support. Because 1 of the DENV-2 isolates sampled in 
2005 clustered with the new clade but fell closer to the 
root of that clade, in situ evolution giving rise to DENV-2 
viruses that subsequently replaced the old clade viruses 
is highly likely. A GenBank sequence that belonged to 
DENV-2, sampled in 2007 in Vietnam, grouped within 
the new clade, indicating that this virus strain was not re-
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Figure 2. Maximum-likelihood tree showing the phylogenetic relationship of A) dengue virus serotype 2 (DENV-2) and B) DENV-3 from 
Singapore and global isolates based on the envelope protein gene. EHI, sequence data generated at Environmental Health Institute; 
new clade, isolates obtained in 2007 and later; old clade, isolates obtained before 2007. Numbers on branches represent bootstrap 
percentages; only those >80% are shown. Scale bars indicate substitutions per site.Dengue Virus Surveillance, Singapore
stricted to Singapore and may have been circulating in 
this region.
Our dengue surveillance also indicated sporadic emer-
gence of DENV-3 from localized areas throughout the 
country (6,10). Phylogenetic analysis of isolates from Sin-
gapore from 2006 through 2008 identiﬁ  ed 3 genotypes of 
DENV-3. These isolates were closely related to those found 
in Indonesia, Malaysia, Philippines, Thailand, Saudi Ara-
bia, and Côte d’Ivoire (Figure 2), which suggests multiple 
importations of DENV-3 viruses into Singapore. Analysis 
of DENV-1 sequences showed that all except 3 belonged 
to genotype I and were similar to those responsible for the 
2005 outbreak (data not shown).
Conclusions
Our dengue surveillance provided early warning of 
the outbreak in 2007 and contributed to early activation 
of enhanced vector control. Although we were unable to 
assess the effectiveness of the control measures, consider-
ing the regional situation in 2007 (11,12), we believe that 
without these measures the dengue situation in Singapore 
in 2007 would have been worse than or comparable to that 
in 2004–2005. After a lull year in 2006, dengue cases were 
expected to rise for a few years. The integrated vector con-
trol program has interrupted the dengue trend, with 7,032 
cases reported in 2008 and 4,498 in 2009.
As a travel hub, Singapore experiences continuous im-
portation of dengue viruses. Although some become estab-
lished at various levels, some develop into outbreaks and 
subsequently get replaced. Our study demonstrates how 
rapidly dengue virus serotypes can be replaced within a 
population. It also highlights the complexity of the disease 
and the challenges faced by affected states that seek to un-
derstand the epidemiology for purposes of disease control. 
To shed further light on the complex interplay among the 
various factors that affect dengue transmission, studies are 
being conducted on complete genome sequences of dengue 
viruses, vectorial capacity of local Aedes spp. mosquitoes, 
and cross-reactive immune responses to different dengue 
serotypes.
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